Publication | Open Access

Single-dose combination nanovaccine induces both rapid and durable humoral immunity and toxin neutralizing antibody responses against Bacillus anthracis

VaccinationNanomedicineCross-protectionDurable Humoral ImmunityImmunologyTherapeutic VaccineHumoral ImmunityMicrobiologyInfection ControlBacillus AnthracisImmunotherapyMedicineVaccine DesignSingle-dose Combination Nanovaccine